Inhaled Nitric Oxide Market Size, Share & Trends Analysis Report By Application (Neonatal respiratory treatment, Chronic obstructive pulmonary disease (COPD), Acute respiratory distress syndrome (ARDS)) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Anantika Sharma | Format: | Report Code: SR1935DR | Pages: 110

Market Segmentation

  1. Inhaled Nitric Oxide Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Neonatal respiratory treatment
    2. Chronic obstructive pulmonary disease (COPD)
    3. Acute respiratory distress syndrome (ARDS)
  2. Regional Inhaled Nitric Oxide Market
    1. North America
      1. North America Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
      2. U.S. Inhaled Nitric Oxide Market
        1. U.S. Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      3. Canada Inhaled Nitric Oxide Market
        1. Canada Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
    2. Europe
      1. Europe Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
      2. U.K. Inhaled Nitric Oxide Market
        1. U.K. Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      3. Germany Inhaled Nitric Oxide Market
        1. Germany Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      4. France Inhaled Nitric Oxide Market
        1. France Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      5. Spain Inhaled Nitric Oxide Market
        1. Spain Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      6. Italy Inhaled Nitric Oxide Market
        1. Italy Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      7. Russia Inhaled Nitric Oxide Market
        1. Russia Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      8. Nordic Inhaled Nitric Oxide Market
        1. Nordic Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      9. Benelux Inhaled Nitric Oxide Market
        1. Benelux Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      10. Rest of Europe Inhaled Nitric Oxide Market
        1. Rest of Europe Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
    3. APAC
      1. APAC Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
      2. China Inhaled Nitric Oxide Market
        1. China Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      3. Korea Inhaled Nitric Oxide Market
        1. Korea Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      4. Japan Inhaled Nitric Oxide Market
        1. Japan Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      5. India Inhaled Nitric Oxide Market
        1. India Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      6. Australia Inhaled Nitric Oxide Market
        1. Australia Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      7. Taiwan Inhaled Nitric Oxide Market
        1. Taiwan Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      8. South East Asia Inhaled Nitric Oxide Market
        1. South East Asia Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      9. Rest of Asia-Pacific Inhaled Nitric Oxide Market
        1. Rest of Asia-Pacific Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
    4. Middle East and Africa
      1. Middle East and Africa Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
      2. UAE Inhaled Nitric Oxide Market
        1. UAE Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      3. Turkey Inhaled Nitric Oxide Market
        1. Turkey Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      4. Saudi Arabia Inhaled Nitric Oxide Market
        1. Saudi Arabia Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      5. South Africa Inhaled Nitric Oxide Market
        1. South Africa Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      6. Egypt Inhaled Nitric Oxide Market
        1. Egypt Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      7. Nigeria Inhaled Nitric Oxide Market
        1. Nigeria Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      8. Rest of MEA Inhaled Nitric Oxide Market
        1. Rest of MEA Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
    5. LATAM
      1. LATAM Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
      2. Brazil Inhaled Nitric Oxide Market
        1. Brazil Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      3. Mexico Inhaled Nitric Oxide Market
        1. Mexico Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      4. Argentina Inhaled Nitric Oxide Market
        1. Argentina Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      5. Chile Inhaled Nitric Oxide Market
        1. Chile Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      6. Colombia Inhaled Nitric Oxide Market
        1. Colombia Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
      7. Rest of LATAM Inhaled Nitric Oxide Market
        1. Rest of LATAM Inhaled Nitric Oxide Market By Application 2022-2034 (USD MILLION/ Units)
          1. Neonatal respiratory treatment
          2. Chronic obstructive pulmonary disease (COPD)
          3. Acute respiratory distress syndrome (ARDS)
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: